| Primary information |
|---|
| PRRID | PRRID_2050 |
| Ligand Name | Flavolipin |
| Source | NA |
| Sequence of ligand | NA |
| Length | NA |
| Type | NA |
| Occurence | Natural |
| Role of Ligand | Low molecular weight HA elicits pro-inflammatory responses by modulating the TLRÔòº or by activating NF-kB; high molecular weight HA manifests an anti-inflammatory effect via CD receptors and by inhibiting NF-kB activation |
| Name of receptor | Toll-like receptor 4 (TLR4) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | NA |
| Localization | Ba/FÔòª cell line |
| Domain | Leucine-rich Repeat (LRR) Domain |
| Sequence of Receptor | NA |
| Swiss prot ID | NA |
| Length Of Receptor | NA |
| Function | NA |
| Assay used | NA |
| PMID | 29028369 |
| Year of Publication | 2017 |
| Pubchem assay | NA |
| Primary information |
|---|
| PRRID | PRRID_2050 |
| Ligand Name | Flavolipin |
| Source | NA |
| Sequence of ligand | NA |
| Length | NA |
| Type | NA |
| Occurence | Natural |
| Role of Ligand | Low molecular weight HA elicits pro-inflammatory responses by modulating the TLRÔòº or by activating NF-kB; high molecular weight HA manifests an anti-inflammatory effect via CD receptors and by inhibiting NF-kB activation |
| Name of receptor | Toll-like receptor 4 (TLR4) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | NA |
| Localization | Ba/FÔòª cell line |
| Domain | Leucine-rich Repeat (LRR) Domain |
| Sequence of Receptor | NA |
| Swiss prot ID | NA |
| Length Of Receptor | NA |
| Function | NA |
| Assay used | NA |
| PMID | 29028369 |
| Year of Publication | 2017 |
| Pubchem assay | NA |